Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,885 INR | -0.42% | -2.00% | +10.64% |
Jun. 29 | Akzo Nobel India Limited Received A Show Cause Notice from the Karnataka GST Department | CI |
May. 28 | Akzo Nobel India Limited Receives Notice from Karnataka GST Department | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.71 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.64% | 1.58B | - | ||
+2.07% | 80.75B | C+ | ||
-11.85% | 34.45B | B- | ||
-12.65% | 30.74B | A- | ||
-10.09% | 15.25B | B | ||
-0.95% | 14.24B | B+ | ||
-22.16% | 10.84B | B+ | ||
+4.36% | 7.82B | B- | ||
-12.99% | 7.34B | B | ||
+5.17% | 3.27B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- AKZOINDIA Stock
- AKZOINDIA Stock
- Ratings Akzo Nobel India Limited